Dr. Paul Kalra and Dr. C. Michael Gibson Discuss: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure with Reduced Ejection Fraction November 6, 2022 Disclosures: TBD
Dr. Petr Ostadal and Dr. C. Michael Gibson Discuss: ECMO-CS – Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Primary Results from the Multicenter, Randomized ECMO-CS Trial November 6, 2022 Disclosures: TBD
Dr. David Hare and Dr. Yazan Daaboul Discuss: RAPCO – Radial Artery Patency and Clinical Outcomes (RAPCO) Randomized Trials – The 15-Year Clinical Outcomes Comparing Radial Artery with Right Internal Thoracic Artery or With Saphenous Vein Grafting November 6, 2022 Disclosures: TBD
Dr. Julian Gillmore, Dr. David Lebwohl, and Dr. C. Michael Gibson Discuss: First-in-Human in vivo Crispr/Cas9 Editing of the Ttr Gene by Ntla-2001 in Patients with Transthyretin Amyloidosis With Cardiomyopathy November 5, 2022 Disclosures: TBA
Dr. Robert Mentz and Dr. C. Michael Gibson Discuss: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Forsumid in Heart Failure: Primary Results of the TRANSFORM-HF Trial November 5, 2022 Disclosures: TBD
Dr. Aruna Pradhan Presents: PROMINENT – A Randomized Trial of Pemafibrate for Triglyceride Reduction in the Prevention of Cardiovascular Disease November 5, 2022 Disclosures: TBD
Dr. Pablo Salinas and Dr. Yazan Daaboul Discuss: Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial September 19, 2022 Disclosure: TBA
Dr. Toshiro Shinke and Dr. C. Michael Gibson Discuss: Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry) September 19, 2022 Disclosure: TBA
Dr. Antonio Mangieri and Dr. C. Michael Gibson Discuss: Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial September 19, 2022 Disclosure: TBA
Dr. Shamir Mehta and Dr. C. Michael Gibson Discuss: Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction September 19, 2022 Disclosure: TBA
